BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, Liu Y, Zhou L, Sun R, Shen S, Li J, Lou J, Zhou H, Wang J, Xu G, Yu Z, Song Y, Chen X. Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. Small 2020;16:e1905233. [PMID: 31814271 DOI: 10.1002/smll.201905233] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 2021;179:114021. [PMID: 34710529 DOI: 10.1016/j.addr.2021.114021] [Reference Citation Analysis]
2 Maleki R, Khedri M, Malekahmadi D, Mohaghegh S, Jahromi AM, Shahbazi M. Simultaneous doxorubicin encapsulation and in-situ microfluidic micellization of bio-targeted polymeric nanohybrids using dichalcogenide monolayers: A molecular in-silico study. Materials Today Communications 2021;26:101948. [DOI: 10.1016/j.mtcomm.2020.101948] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
3 Liu MY, Liu F, Li YJ, Yin JN, Gao YL, Wang XY, Yang C, Liu JG, Li HJ. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway. Oxid Med Cell Longev 2021;2021:5040326. [PMID: 34257801 DOI: 10.1155/2021/5040326] [Reference Citation Analysis]
4 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gong X, Wu J, Wen J, Ding X, Xu N, Sun M, Yu G, Liu S, Zhang B, Liu H. Dual-Ligand-Modified Nanoscale Liposomes Loaded with Curcumin and Metformin Inhibit Drug Resistance and Metastasis of Hepatocellular Carcinoma. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01027] [Reference Citation Analysis]
6 Jin Y, Huynh DTN, Nguyen TLL, Jeon H, Heo KS. Therapeutic effects of ginsenosides on breast cancer growth and metastasis. Arch Pharm Res 2020;43:773-87. [PMID: 32839835 DOI: 10.1007/s12272-020-01265-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dai R, Liu M, Xiang X, Li Y, Xi Z, Xu H. OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives. Front Pharmacol 2022;13:842203. [DOI: 10.3389/fphar.2022.842203] [Reference Citation Analysis]
8 Wang H, Rao B, Lou J, Li J, Liu Z, Li A, Cui G, Ren Z, Yu Z. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Front Cell Dev Biol 2020;8:55. [PMID: 32117981 DOI: 10.3389/fcell.2020.00055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
9 Kong X, Cheng R, Wang J, Fang Y, Hwang KC. Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications. Nano Today 2021;36:101004. [DOI: 10.1016/j.nantod.2020.101004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine. ACS Nano 2020;14:14391-416. [DOI: 10.1021/acsnano.0c07258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
11 Wang Y, Chen J, Tian J, Wang G, Luo W, Huang Z, Huang Y, Li N, Guo M, Fan X. Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01275-2] [Reference Citation Analysis]
12 Gul AR, Shaheen F, Rafique R, Bal J, Waseem S, Park TJ. Grass-mediated biogenic synthesis of silver nanoparticles and their drug delivery evaluation: A biocompatible anti-cancer therapy. Chemical Engineering Journal 2021;407:127202. [DOI: 10.1016/j.cej.2020.127202] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 16.0] [Reference Citation Analysis]
13 Al-Malki AL, Bakkar A, Huwait EA, Barbour EK, Abulnaja KO, Kumosani TA, Moselhy SS. Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line. Biomed Pharmacother 2021;142:111960. [PMID: 34352718 DOI: 10.1016/j.biopha.2021.111960] [Reference Citation Analysis]
14 Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B 2020;8:6333-51. [PMID: 32633311 DOI: 10.1039/d0tb01260b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
15 Chen Z, Zhang Z, Liu J, Qi H, Li J, Chen J, Huang Q, Liu Q, Mi J, Li X. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation. Front Cell Infect Microbiol 2022;12:853981. [DOI: 10.3389/fcimb.2022.853981] [Reference Citation Analysis]
16 Li K, Xiao K, Zhu S, Wang Y, Wang W. Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges. Front Pharmacol 2022;13:889799. [DOI: 10.3389/fphar.2022.889799] [Reference Citation Analysis]
17 Xu F, Li H, Pan Y, Zeng Y, Li J, Li S. Effects of Ganfule capsule on microbial and metabolic profiles in anti-hepatocellular carcinoma. J Appl Microbiol 2021. [PMID: 34564943 DOI: 10.1111/jam.15307] [Reference Citation Analysis]
18 Qu L, Ma X, Fan D. Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis. J Agric Food Chem 2021;69:10121-37. [PMID: 34415764 DOI: 10.1021/acs.jafc.1c03279] [Reference Citation Analysis]
19 Zhao X, Wu J, Zhang K, Guo D, Hong L, Chen X, Wang B, Song Y. The synthesis of a nanodrug using metal-based nanozymes conjugated with ginsenoside Rg3 for pancreatic cancer therapy. Nanoscale Adv 2021;4:190-9. [DOI: 10.1039/d1na00697e] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Liu F, Zhu XT, Li Y, Wang CJ, Fu JL, Hui J, Xiao Y, Liu L, Yan R, Li XF, Liu Y. Magnesium demethylcantharidate inhibits hepatocellular carcinoma cell invasion and metastasis via activation transcription factor FOXO1. Eur J Pharmacol 2021;911:174558. [PMID: 34634308 DOI: 10.1016/j.ejphar.2021.174558] [Reference Citation Analysis]
21 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
22 Liu Z, Bian X, Gao W, Su J, Ma C, Xiao X, Yu T, Zhang H, Liu X, Fan G. Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure. Pharmacol Res 2021;172:105843. [PMID: 34428586 DOI: 10.1016/j.phrs.2021.105843] [Reference Citation Analysis]
23 Lu SL, Wang YH, Liu GF, Wang L, Li Y, Guo ZY, Cheng C. Graphene Oxide Nanoparticle-Loaded Ginsenoside Rg3 Improves Photodynamic Therapy in Inhibiting Malignant Progression and Stemness of Osteosarcoma. Front Mol Biosci 2021;8:663089. [PMID: 33968991 DOI: 10.3389/fmolb.2021.663089] [Reference Citation Analysis]
24 Zhang W, Zhao X, Yuan Y, Miao F, Li W, Ji S, Huang X, Chen X, Jiang T, Weitz DA, Song Y. Microfluidic Synthesis of Multimode Au@CoFeB-Rg3 Nanomedicines and Their Cytotoxicity and Anti-Tumor Effects. Chem Mater 2020;32:5044-56. [DOI: 10.1021/acs.chemmater.0c00797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Xu J, Pan Y, Liu Y, Na S, Zhou H, Li L, Chen F, Song H. A review of anti-tumour effects of ginsenoside in gastrointestinal cancer. J Pharm Pharmacol 2021;73:1292-301. [PMID: 33836068 DOI: 10.1093/jpp/rgab048] [Reference Citation Analysis]
26 Kim B, Park JE, Im E, Cho Y, Lee J, Lee HJ, Sim DY, Park WY, Shim BS, Kim SH. Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression. Int J Mol Sci 2021;22:3571. [PMID: 33808235 DOI: 10.3390/ijms22073571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang HQ, Chen G, Xiong DD, Lai ZF, Liu LM, Fang YY, Shen JH, Gan XY, Liao LF, Dang YW. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. Bioengineered 2021;12:1627-41. [PMID: 33949293 DOI: 10.1080/21655979.2021.1921549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Li S, Li S, Lin M, Li Z, He J, Qiu J, Zhang J. Interleukin-17 and vascular endothelial growth factor: new biomarkers for the diagnosis of papillary thyroid carcinoma in patients with Hashimoto's thyroiditis. J Int Med Res 2022;50:3000605211067121. [PMID: 35023376 DOI: 10.1177/03000605211067121] [Reference Citation Analysis]